These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2173848)
21. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans. Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis A vaccine: evidence of efficacy after exposure. Commun Dis Rep CDR Wkly; 1999 Apr; 9(16):139, 142. PubMed ID: 10341473 [No Abstract] [Full Text] [Related]
23. [The future of viral hepatitis vaccines]. Shdanov VM Z Gesamte Hyg; 1985 Mar; 31(3):134-7. PubMed ID: 2990115 [No Abstract] [Full Text] [Related]
24. Public health control of hepatitis A: memorandum from a WHO meeting. Bull World Health Organ; 1995; 73(1):15-20. PubMed ID: 7704922 [TBL] [Abstract][Full Text] [Related]
25. [Prevention of hepatitis A]. Wagner G Rev Med Suisse Romande; 1993 Mar; 113(3):191-2. PubMed ID: 8386849 [No Abstract] [Full Text] [Related]
26. [Etiology, diagnosis and the prospects for vaccinal prevention of hepatitis A]. Balaian MS Vestn Akad Med Nauk SSSR; 1983; (12):30-7. PubMed ID: 6320550 [No Abstract] [Full Text] [Related]
27. Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects. Ackerman Z; Ablin J; Shouval D Am J Gastroenterol; 1996 Feb; 91(2):413. PubMed ID: 8607537 [No Abstract] [Full Text] [Related]
28. [Costs of hepatitis A prophylaxis in travelers]. Zaaijer HL; Lelie PN Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787 [No Abstract] [Full Text] [Related]
29. Hepatitis A: a vaccine at last. Lancet; 1992 May; 339(8803):1198-9. PubMed ID: 1349941 [No Abstract] [Full Text] [Related]
30. Hepatitis A and B vaccines in children. Lieberman JM; Greenberg DP Adv Pediatr Infect Dis; 1996; 11():333-63. PubMed ID: 8718466 [No Abstract] [Full Text] [Related]
31. [Observation of live, attenuated hepatitis A vaccines in humans]. Hu MD Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):65-8. PubMed ID: 8394801 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine. Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923 [TBL] [Abstract][Full Text] [Related]
33. [The design and practical use of vaccines for the preventions of pressing viral infections]. Grachev VP Vopr Virusol; 2005; 50(3):32-6. PubMed ID: 16078432 [TBL] [Abstract][Full Text] [Related]
34. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?]. Leentvaar-Kuijpers A Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784 [No Abstract] [Full Text] [Related]
35. [Initial experience with an inactivated anti-hepatitis-A vaccine]. Panà A; Franco E; Divizia M Nuovi Ann Ig Microbiol; 1988; 39(4-5):373-7. PubMed ID: 2855448 [No Abstract] [Full Text] [Related]
36. The value of immunization against hepatitis A. Lemon SM; Shapiro CN Infect Agents Dis; 1994 Feb; 3(1):38-49. PubMed ID: 7952926 [TBL] [Abstract][Full Text] [Related]
37. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver]. Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537 [No Abstract] [Full Text] [Related]
38. [Recommendations for the use of the hepatitis A vaccine in day care centers. Committee on Vaccines of the Spanish Pediatric Society and Spanish Association for the Study of the Liver]. Gastroenterol Hepatol; 1998; 21(7):346-51. PubMed ID: 9808900 [No Abstract] [Full Text] [Related]